Robin Yabroff, PhD, is an epidemiologist and Senior Scientific Director, Health Services Research, at the American Cancer Society. She conducts research on financial hardship and economic burden of cancer; patterns of cancer care, including high-cost prescription drugs; health insurance benefit design; and patient, provider, and health system factors associated with quality and value of cancer care. Dr. Yabroff has more than 25 years of health services research experience. Prior to joining the American Cancer Society, she held positions within the Office of Health Policy, Assistant Secretary for Planning and Evaluation, in the U.S. Department of Health and Human Services, the Health Services and Economics Branch of the National Cancer Institute, and the faculty of the Lombardi Cancer Center, Georgetown University. She currently serves as an adjunct associate professor in the Department of Medicine, the Johns Hopkins University, and adjunct professor in the Department of Health Policy and Management, Rollins School of Public Health, Emory University.
Dr. Yabroff has co-authored over 150 peer-reviewed journal articles, and co-authored invited editorials, commentaries, and book chapters. She is an associate editor for the Journal of the National Cancer Institute, a founding member of the editorial board of the Journal of Cancer Survivorship, and a member of the editorial board of the JCO Oncology Practice. She served as a guest editor for the Medical Care journal supplement, “Health Care Costing: Data, Methods, Future Directions,” and the Journal of the National Cancer Institute journal supplement, “Comparing Cancer Care and Economic Outcomes Across Health Systems: Challenges and Opportunities.” Dr. Yabroff received multiple National Institutes of Health Merit Awards for her research leadership and mentorship. She is a frequent speaker at national and international research meetings and serves as a panelist and think tank participant on topics related to economic burden of cancer, financial hardship, and the role of health insurance in access to high-quality cancer care.